1,3-dipropyl-8-cyclopentylxanthine has been researched along with diadenosine tetraphosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jankowski, J; Schlüter, H; Tepel, M; van der Giet, M; Zidek, W | 1 |
Bokník, P; Deng, MC; Gombosová, I; Huke, S; Jankowski, H; Knapp, J; Linck, B; Lüss, H; Müller, FU; Neumann, J; Scheld, HH; Schlüter, H; Schmitz, W; Vahlensieck, U; Zidek, W; Zimmermann, N | 1 |
Al-Hrasen, MN; El-Hadiyah, TM; Khattab, MM | 1 |
3 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and diadenosine tetraphosphate
Article | Year |
---|---|
Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors.
Topics: Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Dinucleoside Phosphates; In Vitro Techniques; Male; Perfusion; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic; Receptors, Purinergic P1; Receptors, Purinergic P2; Renal Artery; Thionucleotides; Vasoconstrictor Agents; Vasodilator Agents; Xanthines | 1998 |
Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations.
Topics: Animals; Calcium; Calcium Channels; Cells, Cultured; Dinucleoside Phosphates; Drug Interactions; Guinea Pigs; Heart; Heart Atria; Heart Ventricles; Humans; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Platelet Aggregation Inhibitors; Xanthines | 1999 |
Contractile activity of ATP and diadenosine tetraphosphate on urinary bladder in the rat: role of A1- and P2X-purinoceptors and nitric oxide.
Topics: Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Dinucleoside Phosphates; In Vitro Techniques; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Purinergic P2; Receptors, Purinergic P2X; Urinary Bladder; Xanthines | 2007 |